Search filters

List of works by Amy Jo Chien

A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel.

scientific article

A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies.

scientific article published on 13 February 2016

A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer ⬇️

scientific article published on December 24, 2011

Abstract P3-03-07: Single-institution retrospective analysis of lymph node (LN) change on breast MRI in patients with high risk early-stage breast cancer receiving neoadjuvant chemotherapy with and without immunotherapy on the ISPY-2 TRIAL

scientific article published in 2022

Acute ovarian failure underestimates age‐specific reproductive impairment for young women undergoing chemotherapy for cancer ⬇️

scientific article published on August 17, 2011

Adaptive Randomization of Neratinib in Early Breast Cancer

scientific article published on July 2016

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer

scientific article published on July 2016

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical T

scientific article published on 23 July 2020

Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer

scientific article

Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival

scientific article published on 21 November 2020

Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy

scientific article published on 09 June 2020

Developing Safety Criteria for Introducing New Agents into Neoadjuvant Trials ⬇️

scientific article published on March 7, 2013

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

scientific article published on 13 February 2020

Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer

scientific article

Erratum to: Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy

scientific article published on 28 June 2017

Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer

scientific article published on 17 July 2020

Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation

scientific article published on 22 October 2019

Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy

scientific article published on 13 May 2017

Fitbit Usage in Patients With Breast Cancer Undergoing Chemotherapy

scientific article published on 25 May 2019

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

scientific article published on 05 October 2021

HER2-positive breast cancer: is more treatment better?

scientific article published on 10 February 2016

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: diarrheal toxicity in the CONTROL trial

scientific article published on 25 May 2020

Lapatinib: new directions in HER2 directed therapy for early stage breast cancer

scientific article published on January 2009

MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial

scientific article published on 07 February 2019

Mechanism of action biomarkers predicting response to AKT inhibition in the I-SPY 2 breast cancer trial

scientific article published on 02 October 2020

Phase I dose-escalation study of 5-day intermittent oral lapatinib therapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer

scientific article

Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer

scientific article published on September 2011

The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer

scientific article published on 24 February 2015

The cardiac safety of trastuzumab in the treatment of breast cancer

scientific article published on March 2010

The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivors ⬇️

scientific article published on July 15, 2012

The value of embedding: integrated palliative care for patients with metastatic breast cancer.

scientific article published on 30 October 2017

Use of 18F-FDG PET/CT as an Initial Staging Procedure for Stage II-III Breast Cancer: A Multicenter Value Analysis

scientific article published on 02 November 2020

Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial

scientific article

Paulina is supported by:

About Paulina

Help